Posted On: 06/22/2014 11:56:20 AM
Post# of 74551
$CHTP Headlines
U.S. stocks fall on Fed fears after S&P 500 nears high 5:49 p.m. Feb. 19, 2014 - Anora Mahmudova
Zale soars on deal; U.S. Steel down on tariff ruling 5:33 p.m. Feb. 19, 2014 - Sue Chang
Kiev in flames, consumer-stock flop, Europe on top and an inflation surprise 9:37 a.m. Feb. 19, 2014 - Barbara Kollmeyer
Chelsea shares jump 35% after hours on hypotension drug approval 8:01 p.m. Feb. 18, 2014 - Russ Britt
Herbalife shares rise on earnings, La-Z-Boy drops 7:22 p.m. Feb. 18, 2014 - Wallace Witkowski
Chelsea Therapeutics shares are halted: Nasdaq 5:17 p.m. Feb. 18, 2014 - Laura Mandaro
Wednesday’s movers: Herbalife slumps after call 5:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 7:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 1:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 10:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 8:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 8:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 12:10 p.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 2:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 8:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 7:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 5:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 11:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 12:15 p.m. July 26, 2011 - Val Brickates Kennedy
Lundbeck Delivers Some Data-Driven Upside 7:00 a.m. June 20, 2014 - Seeking Alpha
Waiting period over for Chelsea-Lundbeck transaction 7:37 a.m. June 6, 2014 - Seeking Alpha
Chelsea Therapeutics Deal Terms: Be Careful 12:18 p.m. June 2, 2014 - Seeking Alpha
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside 9:00 a.m. May 29, 2014 - Seeking Alpha
Lundbeck Starting Slow, But Still Looking For The Big Finish 11:35 a.m. May 9, 2014 - Seeking Alpha
Lundbeck to Buy Chelsea Therapeutics for $658M 11:31 a.m. May 8, 2014 - TheStreet.com
Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today 10:05 a.m. May 8, 2014 - TheStreet.com
Chelsea Exits in Victory With Lundbeck Takeout 9:05 a.m. May 8, 2014 - TheStreet.com
More on Chelsea-Lundbeck deal: Lundbeck gains rights to Northera 8:36 a.m. May 8, 2014 - Seeking Alpha
Chelsea Therapeutics International Enters Oversold Territory (CHTP) 12:27 p.m. April 15, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Chelsea Therapeutics Posts Wider Q4 Loss - Analyst Blog 1:41 p.m. March 12, 2014 - Zacks.com
10-K: CHELSEA THERAPEUTICS INTERNATIONAL, LTD. 4:22 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: Caution Warranted 9:49 a.m. Feb. 25, 2014 - Seeking Alpha
Company news for February 20, 2014 - Corporate Summary 11:06 a.m. Feb. 20, 2014 - Zacks.com
CHTP's Northera Gains FDA Approval - Analyst Blog 7:20 p.m. Feb. 19, 2014 - Zacks.com
Chelsea Moving on to the Revenue Stage of Its Cycle 11:00 a.m. Feb. 19, 2014 - 247WallSt.com
Analysts add to Chelsea feel-good factor 10:38 a.m. Feb. 19, 2014 - Seeking Alpha
NORTHERA(TM) Clinical Trial Data Published in Neurology 4:30 p.m. June 19, 2014 - GlobeNewswire
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders 7:29 a.m. June 12, 2014 - GlobeNewswire
Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition of Chelsea Therapeutics by Lundbeck 7:00 a.m. June 6, 2014 - GlobeNewswire
The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. 3:32 p.m. June 2, 2014 - PR Newswire - PRF
Active Stocks Technical Coverage -- Research on Callaway Golf, Annaly Capital Management, Weatherford Intl., and Chelsea Therapeutics Intl. 11:11 a.m. May 21, 2014 - PR Newswire - PRF
Chelsea Therapeutics Shareholder Alert:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Acquisition Proposal from H. Lundbeck A/S 10:58 a.m. May 21, 2014 - BusinessWire - BZX
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests 11:44 a.m. May 12, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd. 9:15 p.m. May 9, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd. 8:40 p.m. May 9, 2014 - PR Newswire - PRF
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc. 7:51 p.m. May 9, 2014 - PR Newswire - PRF
Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:35 a.m. May 9, 2014 - PR Newswire - PRF
Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:09 a.m. May 9, 2014 - BusinessWire - BZX
Law Offices of Marc S. Henzel Announces Securities Class Action Periods 9:11 a.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S 9:00 p.m. May 8, 2014 - BusinessWire - BZX
CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd. 8:45 p.m. May 8, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders 6:35 p.m. May 8, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests 5:25 p.m. May 8, 2014 - PR Newswire - PRF
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 1:22 p.m. May 8, 2014 - BusinessWire - BZX
U.S. stocks fall on Fed fears after S&P 500 nears high 5:49 p.m. Feb. 19, 2014 - Anora Mahmudova
Zale soars on deal; U.S. Steel down on tariff ruling 5:33 p.m. Feb. 19, 2014 - Sue Chang
Kiev in flames, consumer-stock flop, Europe on top and an inflation surprise 9:37 a.m. Feb. 19, 2014 - Barbara Kollmeyer
Chelsea shares jump 35% after hours on hypotension drug approval 8:01 p.m. Feb. 18, 2014 - Russ Britt
Herbalife shares rise on earnings, La-Z-Boy drops 7:22 p.m. Feb. 18, 2014 - Wallace Witkowski
Chelsea Therapeutics shares are halted: Nasdaq 5:17 p.m. Feb. 18, 2014 - Laura Mandaro
Wednesday’s movers: Herbalife slumps after call 5:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 7:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 1:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 10:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 8:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 8:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 12:10 p.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 2:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 8:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 7:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 5:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 11:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 12:15 p.m. July 26, 2011 - Val Brickates Kennedy
Lundbeck Delivers Some Data-Driven Upside 7:00 a.m. June 20, 2014 - Seeking Alpha
Waiting period over for Chelsea-Lundbeck transaction 7:37 a.m. June 6, 2014 - Seeking Alpha
Chelsea Therapeutics Deal Terms: Be Careful 12:18 p.m. June 2, 2014 - Seeking Alpha
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside 9:00 a.m. May 29, 2014 - Seeking Alpha
Lundbeck Starting Slow, But Still Looking For The Big Finish 11:35 a.m. May 9, 2014 - Seeking Alpha
Lundbeck to Buy Chelsea Therapeutics for $658M 11:31 a.m. May 8, 2014 - TheStreet.com
Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today 10:05 a.m. May 8, 2014 - TheStreet.com
Chelsea Exits in Victory With Lundbeck Takeout 9:05 a.m. May 8, 2014 - TheStreet.com
More on Chelsea-Lundbeck deal: Lundbeck gains rights to Northera 8:36 a.m. May 8, 2014 - Seeking Alpha
Chelsea Therapeutics International Enters Oversold Territory (CHTP) 12:27 p.m. April 15, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Chelsea Therapeutics Posts Wider Q4 Loss - Analyst Blog 1:41 p.m. March 12, 2014 - Zacks.com
10-K: CHELSEA THERAPEUTICS INTERNATIONAL, LTD. 4:22 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: Caution Warranted 9:49 a.m. Feb. 25, 2014 - Seeking Alpha
Company news for February 20, 2014 - Corporate Summary 11:06 a.m. Feb. 20, 2014 - Zacks.com
CHTP's Northera Gains FDA Approval - Analyst Blog 7:20 p.m. Feb. 19, 2014 - Zacks.com
Chelsea Moving on to the Revenue Stage of Its Cycle 11:00 a.m. Feb. 19, 2014 - 247WallSt.com
Analysts add to Chelsea feel-good factor 10:38 a.m. Feb. 19, 2014 - Seeking Alpha
NORTHERA(TM) Clinical Trial Data Published in Neurology 4:30 p.m. June 19, 2014 - GlobeNewswire
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders 7:29 a.m. June 12, 2014 - GlobeNewswire
Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition of Chelsea Therapeutics by Lundbeck 7:00 a.m. June 6, 2014 - GlobeNewswire
The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. 3:32 p.m. June 2, 2014 - PR Newswire - PRF
Active Stocks Technical Coverage -- Research on Callaway Golf, Annaly Capital Management, Weatherford Intl., and Chelsea Therapeutics Intl. 11:11 a.m. May 21, 2014 - PR Newswire - PRF
Chelsea Therapeutics Shareholder Alert:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Acquisition Proposal from H. Lundbeck A/S 10:58 a.m. May 21, 2014 - BusinessWire - BZX
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests 11:44 a.m. May 12, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd. 9:15 p.m. May 9, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd. 8:40 p.m. May 9, 2014 - PR Newswire - PRF
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc. 7:51 p.m. May 9, 2014 - PR Newswire - PRF
Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:35 a.m. May 9, 2014 - PR Newswire - PRF
Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd. 10:09 a.m. May 9, 2014 - BusinessWire - BZX
Law Offices of Marc S. Henzel Announces Securities Class Action Periods 9:11 a.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S 9:00 p.m. May 8, 2014 - BusinessWire - BZX
CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd. 8:45 p.m. May 8, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders 6:35 p.m. May 8, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests 5:25 p.m. May 8, 2014 - PR Newswire - PRF
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 1:22 p.m. May 8, 2014 - BusinessWire - BZX
(0)
(0)
